DOCSLIB.ORG

BIN DENG Curriculum Vitae MGH/HST Athinoula A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

BIN DENG Curriculum Vitae MGH/HST Athinoula A. Martinos Center for Biomedical Imaging 149 13th St., Suite 2280-B, Charlestown, MA, 02129 [email protected] (617) 726-9338 EDUCATION Syracuse University, Syracuse, NY Doctor of Philosophy, Bioengineering August 2012 Thesis: The role of fluorescence and human factors in quantitative transdermal blood and tissue analysis using NIR Raman spectroscopy Advisor: Prof. Joseph Chaiken Tianjin University, College of Precision Instrument & Optoelectronics Engineering, China Master of Science, Measuring and Testing Technology and Instrument March 2007 Thesis: Theoretical and experimental study on effective extraction of glucose specific signal in NIR spectroscopy Advisor: Prof. Kexin Xu Bachelor of Science, Biomedical Engineering July 2004 Senior Thesis: Mechanical design and application of DOAS (differential optical absorption spectroscopy) system for atmospheric quality monitoring Advisor: Prof. Yan Wang PROFESSIONAL POSITIONS 10/2012 – 10/2013 Application Scientist LighTouch Medical, Inc. 10/2013 – 03/2018 Research Fellow Massachusetts General Hospital Martinos Center for Biomedical Imaging 03/2018 – present Instructor Harvard Medical School Research Staff MGH – Martinos Center RESEARCH EXPERIENCE >> Research Fellow, MGH Martinos Center for Biomedical Imaging October 2013 – March 2018 • Multi-parametric breast imaging that combines functional diffuse optical tomography (DOT), functional MRI, and MR Elastography for monitoring treatment responses of breast cancer; • Multi-modality imaging for early breast cancer diagnosis by combining DOT with structural 3D digital breast tomosynthesis (DBT); • Validated a new method of combining stand-alone 2D mammogram with functional DOT imaging in a 34-sample clinical trial. 2D-guided optical reconstruction reveals similar statistics to spatially co-registered 3D-guided reconstruction in differentiating tumor from other tissues; • Tissue segmentation algorithm development for anatomical structure prior generation to guide optical image reconstruction. >> Application Scientist, LighTouch Medical, Inc. October 2012 – October 2013 • Played leading role in planning and executing a military contract of investigating hematocrit, plasma protein and fluid shifting in a simulated internal hemorrhage scenario based on a cannulated rat model; • Developed and validated the first Raman based noninvasive continuous hematocrit monitoring prototype for clinical settings, and coordinated with nephrologists and nurse practitioners to collect clinical trials data for 9 volunteers at a local dialysis center; • Design of experiments, bulk-volume spectral data processing, analysis and interpretation. >> Research Assistant, Prof. Joseph Chaiken’s Group August 2007 – August 2012 • Engineered an improved prototype of in vivo non-invasive human blood glucose concentration detection Raman system which incorporated a novel PDPM human-machine interface; • Developed algorithm to calculate hematocrit using combined tissue elastic and inelastic emission; • Investigated the fluorescence and photo-dynamics of various constituents in epithelial tissue, ECM and blood cells, including hemoglobin, plasma, sugars, collagen, AGEs, etc.; • Applied Raman spectroscopy in characterizing chemical changes in glial scar formation and the effectiveness of chondroitinase treatment after traumatic spinal cord injury. >> Research Assistant, Prof. Kexin Xu’s Group September 2004 – February 2007 • Introduced a novel reference wavelength based analyte-specific spectral signal extraction algorithm according to the water displacement by solute molecules; • Applied chemometrics, such as PCA, PLS and NAS, in post-experiment data processing to effectively filter the background noise, thus improve the detection sensitivity; • Validated the feasibility of using NIR absorption and diffuse reflectance spectroscopy in non- invasive blood glucose monitoring in a rabbit animal model. >> Optical Engineer, Internship: SUNshine Optics Technology Co. Ltd. Tianjin Spring 2004 • Team worked in the optical route and mechanical structure design for an air quality monitoring system based on differential optical absorption spectroscopy; • Built a database of project-relevant ISO, EN, and GB standards for commercial manufacture. TECHNICAL SKILLS Medical Imaging: DOT, MRI, MRE, X-ray mammogram, Ultrasound Spectroscopy: NIR, Raman, FT-IR, MALDI-TOF, LC/MS, UV-VIS, NMR Microscopy: Polarized light microscope, FT-IR microscope, Confocal Raman, AFM Material Analysis: HPLC, DLS, Rotational Rheometer, TGA, Refractometer Programming: MATLAB, R, Python, MySQL, SAS, VBA for Excel, C++ Data Processing: PLS, PCA, NAS, KNN, Regression Analysis, Statistical tests, Neural Networks Software Strength: OriginPro, LabVIEW, Unscrambler, GRAMS, ImageJ, Gaussian, OMNIC, JMP Animal Surgery: IACUC trained, Cannulated rat model, Rabbit model Technical Writings: IRB protocols, SOPs, Informed consent, Funding proposals PUBLICATIONS 1. Bin Deng, Mats Lundqvist, Qianqian Fang, Stefan A. Carp, “Impact of errors in experimental parameters on reconstructed breast images using diffuse optical tomography”, Biomedical Optics Express, 9(3), 1130-50, 2018 2. Bernhard B. Zimmermann, Bin Deng, Bhawana Singh, Mark Martino, Juliette Selb, Qianqian Fang, Amir Y. Sajjadi, Jayne Cormier, Richard M. Moore, Daniel B. Kopans, David A. Boas, BIN DENG Page 2 Mansi A. Saksena, Stefan A. Carp, “Multi-Modal Breast Cancer Imaging using Co-Registered Dynamic Diffuse Optical Tomography and Digital Breast Tomosynthesis”, Journal of Biomedical Optics, 22(4), 046008, 2017 3. Amir Y. Sajjadi, Steven J. Isakoff, Bin Deng, Bhawana Singh, Christy M. Wanyo, Qianqian Fang, Michelle C. Specht, Lidia Schapira, Beverly Moy, Aditya Bardia, David A. Boas, Stefan A. Carp, “Normalization of compression-induced hemodynamics in patients responding to neoadjuvant chemotherapy monitored by dynamic tomographic optical breast imaging (DTOBI)”, Biomedical Optics Express, 8(2), 555-569, 2017 4. Paul Dent, Bin Deng, Jerry Goodisman, Charles M. Peterson, Sriram Narsipur, Joseph Chaiken, “Noninvasive in vivo plasma volume and hematocrit in humans: observing long-term baseline behavior to establish hemostasis for intravascular volume and composition”, Proc. of SPIE, Vol. 9887, 98871S, 2016 5. Bin Deng, Maxim Fradkin, Jean-Michel Rouet, Richard H. Moore, Daniel B. Kopans, David A. Boas, Mats Lundqvist, Qianqian Fang, “Characterizing breast lesions through robust multimodal data fusion using independent diffuse optical and x-ray breast imaging”, Journal of Biomedical Optics, 20(8), 080502, 2015 6. Bin Deng, Dana H. Brooks, David A. Boas, Mats Lundqvist, Qianqian Fang, “Characterization of structural-prior guided optical tomography using realistic breast models derived from dual- energy x-ray mammography”, Biomedical Optics Express, 6(7), 2366-2379, 2015 7. Paul Dent, Bin Deng, Jerry Goodisman, Joseph Chaiken, “Coupled turbidity and spectroscopy problems: a simple algorithm for volumetric analysis of optically thin or dilute 2-phase systems”, Applied Spectroscopy, 69(3), 377-388, 2015 8. Bin Deng, Evan Kastner, Sriram Narsipur, Jerry Goodisman, Joseph Chaiken, “Continuous noninvasive in vivo monitoring of intravascular plasma volume and hematocrit changes during hemodialysis in humans: direct comparison with the CRIT-LINE”, Proc. of SPIE, Vol. 8935, 89351N-11, 2014 9. Bin Deng, Evan Kastner, Paul Dent, Jerry Goodisman, Joseph Chaiken, “Continuous non- invasive in vivo monitoring of intravascular plasma volume and hematocrit changes in response to blood removal and fluid replacement in a rat model”, Proc. of SPIE, Vol. 8935, 893526, 2014 10. Bin Deng, “The role of fluorescence and human factors in quantitative transdermal blood and tissue analysis using NIR Raman spectroscopy”, Syracuse University, Biomedical and Chemical Engineering – Dissertations, Paper 64, 2012 11. Bin Deng, Anabel Simental, Patrick Lutz, George Shaheen, Joseph Chaiken, “Singlet oxygen induced advanced glycation endproduct photobleaching of in vivo human fingertip autofluorescence”, Proc. of SPIE, Vol. 8219, 82190D, 2012 12. Joseph Chaiken, Bin Deng, Jerry Goodisman, George Shaheen, Rebecca J. Bussjager, “Analyzing near infrared scattering from human skin to monitor changes in hematocrit”, Proc. of SPIE, Vol.8219, 821908, 2012 13. Joseph Chaiken, Bin Deng, Jerry Goodisman, G. Shaheen, R. J. Bussjager, “Analyzing near- infrared scattering from human skin to monitor changes in hematocrit”, Journal of Biomedical Optics, 16(9), 097005, 2011 14. Tarun Saxena, Bin Deng, Dennis Stelzner, Julie Hasenwinkel, Joseph Chaiken, “Raman spectroscopic investigation of spinal cord injury in a rat model”, Journal of Biomedical Optics, BIN DENG Page 3 16(2), 027003, 2011 15. Tarun Saxena, Bin Deng, Kyle Hoellger, Eric Lewis-Clark, Julie M. Hasenwinkel, Joseph Chaiken, “Near infra-red Raman spectroscopic study of reactive gliosis and the glial scar in injured rat spinal cords”, Proc. of SPIE, Vol.7560, 75600I, 2010 16. Bin Deng, Colin Wright, Eric Lewis-Clark, George Shaheen, Roman Geier, Joseph Chaiken, “Direct noninvasive observation of near infrared photobleaching of autofluorescence in human volar side fingertips in vivo”, Proc. of SPIE, Vol. 7560, 75600P, 2010 17. Joseph Chaiken, Bin Deng, Rebecca J. Bussjager, George Shaheen, David Rice, Dave Stehlik, John Fayos, “Instrument for near infrared emission spectroscopic probing of human fingertips in vivo”, Review of Scientific Instruments, 81, 034301, 2010 18. Joseph Chaiken, Jerry Goodisman, Bin
Recommended publications
  • Three-Dimensional (3D) Digital Breast Tomosynthesis (DBT) in the Early Diagnosis and Detection of Breast Cancer

    Three-Dimensional (3D) Digital Breast Tomosynthesis (DBT) in the Early Diagnosis and Detection of Breast Cancer

    Julkaisu 594 Publication 594 Mari Varjonen Three-Dimensional (3D) Digital Breast Tomosynthesis (DBT) in the Early Diagnosis and Detection of Breast Cancer Tampere 2006 Tampereen teknillinen yliopisto. Julkaisu 594 Tampere University of Technology. Publication 594 Mari Varjonen Three-Dimensional (3D) Digital Breast Tomosynthesis (DBT) in the Early Diagnosis and Detection of Breast Cancer Thesis for the degree of Doctor of Technology to be presented with due permission for public examination and criticism in Rakennustalo Building, Auditorium RG202, at Tampere University of Technology, on the 12th of May 2006, at 12 noon. Tampereen teknillinen yliopisto - Tampere University of Technology Tampere 2006 Supervisors: Professor Jari Hyttinen Tampere University of Technology, Tampere, Finland. Docent Martti Pamilo Mammography Screening, Health Services Research Ltd; and University of Helsinki, Finland. Reviewers: Professor Daniel B Kopans Harvard Medical School; and Massachusetts General Hospital, Boston, USA. Professor Martin J Yaffe Sunnybrook & Women's College Health Sciences Centre; and University of Toronto, Toronto, Canada. Opponents: Professor Peter B Dean University of Turku; and Turku University Hospital, Turku, Finland. Professor Daniel B Kopans Harvard Medical School; and Massachusetts General Hospital, Boston, USA. ISBN 952-15-1584-8 (printed) ISBN 952-15-1585-6 (PDF) ISSN 1459-2045 Acknowledgements i ACKNOWLEDGEMENTS First and foremost I want to thank every woman who participated in the breast tomosynthesis study for the early diagnosis and detection of breast cancer. Without a doubt, you are the bravest group of ladies that I have ever met. Clinical research for this thesis was conducted at the Helsinki University Central Hospital Mammography Department, Helsinki, Finland and the Jane Brattain Breast Center Park Nicollet Clinic, Minneapolis, USA from 2001-2004.
  • Appropriate Imaging for Breast Cancer Screening

    Appropriate Imaging for Breast Cancer Screening

    Appropriate Imaging for Breast Cancer Screening Draft Key Questions: Public Comment & Response August 22, 2014 Health Technology Assessment Program (HTA) Washington State Health Care Authority PO Box 42712 Olympia, WA 98504-2712 (360) 725-5126 www.hca.wa.gov/hta [email protected] Appropriate Imaging for Breast Cancer Screening Draft Key Questions Public Comment and Response August 22, 2014 WA – Health Technology Assessment August 22, 2014 Response to Public Comments The Institute for Clinical and Economic Review (ICER) is an independent vendor contracted to produce evidence assessment reports for the Washington HTA program. For transparency, all comments received during the public comment period are included in this response document. Comments related to program decisions, process, or other matters not pertaining specifically to the draft key questions, project scope, or evidence assessment are acknowledged through inclusion only. This document responds to comments from the following parties: Draft Key Questions Murray Rebner, MD, FACR, President, Society of Breast Imaging; Director, Section of Breast Imaging, Beaumont Hospitals; Professor, Diagnostic Radiology, Oakland University William Beaumont School of Medicine; and Daniel Kopans, MD, FACR, Director and Chair of Fellows, Society of Breast Imaging; Professor Radiology, Harvard Medical School; Senior Radiologist, Breast Imaging Division, Massachusetts General Hospital Avon Comprehensive Breast Evaluation Center Matthew Larson, MBA, Gig Harbor, WA Gail Rodriguez, PhD, Executive Director,
  • Archived Scope 2005

    Archived Scope 2005

    Archived Scope 2005 Archived Scope 2005 Scope Vol. 9 No. 1 (January 10, 2005) Scope Vol. 9 No 26 (July 4, 2005) Scope Vol. 9 No. 2 (January 17, 2005) Scope Vol. 9 No 27 (July 11, 2005) Scope Vol. 9 No. 3 (January 24, 2005) Scope Vol. 9 No 28 (July 18, 2005) Scope Vol. 9 No. 4 (January 31, 2005) Scope Vol. 9 No 29 (August 1, 2005) Scope Vol. 9 No. 5 (February 7, 2005) Scope Vol. 9 No 30 (August 22, 2005) Scope Vol. 9 No. 6 (February 14, 2005) Scope Vol. 9 No 31 (August 29, 2005) Scope Vol. 9 No. 7 (February 21, 2005) Scope Vol. 9 No 32 (September 2, 2005) Scope Vol. 9 No. 8 (February 28, 2005) Scope Vol. 9 No 33 (September 9, 2005) Scope Vol. 9 No. 9 (March 7, 2005) Scope Vol. 9 No 34 (September 16, 2005) Scope Vol. 9 No. 10 (March 14, 2005) Scope Vol. 9 No 35 (September 23, 2005) Scope Vol. 9 No. 11 (March 21, 2005) Scope Vol. 9 No 36 (September 30, 2005) Scope Vol. 9 No. 12 (March 28, 2005) Scope Vol. 9 No 37 (October 7, 2005) Scope Vol. 9 No. 13 (April 4, 2005) Scope Vol. 9 No 38 (October 14, 2005) Scope Vol. 9 No. 14 (April 11, 2005) Scope Vol. 9 No 39 (October 21, 2005) Scope Vol. 9 No. 15 (April 18, 2005) Scope Vol. 9 No 40 (October 28, 2005) Scope Vol. 9 No. 16 (April 25, 2005) Scope Vol. 9 No 41 (November 4, 2005) Scope Vol.
  • Commentary Daniel Kopans, MD on USPSTF

    Commentary Daniel Kopans, MD on USPSTF

    Commentary Daniel Kopans, MD on USPSTF The US Preventive Services Task Force (USPSTF) used the lowest possible decrease in deaths from mammography in their estimates of how many women would need mammograms to save one life. They also ignored direct data that would have provided them with a more accurate measure of benefit. A truly scientific analysis would have explained the following and provided a range. The USPSTF used a 15% decrease in breast cancer deaths in their calculations of how many women would need to be screened to save one life. This is, in fact, the lowest possible estimate of benefit which they derived from the randomized, controlled trials (RCT). It is clear that the members are unfamiliar with RCT and how the data are analyzed. In the RCT, women were “invited” to be screened (they obviously cannot be forced to participate). This means that the RCT underestimate the benefit of screening since women who are allocated to the screening arm who refuse the invitation to be screened (noncompliance) and die of breast cancer are still counted as deaths in the screened group. Similarly, women allocated to the “unscreened” control group were free to have mammograms on their own outside the trials. Despite the fact that these mammograms may have prevented them from dying of breast cancer, they are still counted as unscreened controls (contamination). It is clear that the members of the USPSTF actually did not understand that the trials underestimate the benefit. If they did, then they were negligent in not explaining this to the public. A more accurate measure of how much the death rate will go down in true population screening is obtained by actually measuring the decrease in deaths when the population is screened.
  • June 1, 2011 Volume 3, Number 11 Radical Views

    June 1, 2011 Volume 3, Number 11 Radical Views

    A teaching hospital of Harvard Medical School June 1, 2011 Volume 3, Number 11 Radical Views... from the Department of Radiology June 2011 Mon Tues Wed Thurs Fri 1 2 3 3:00-4:00 1:00-2:00 Weekly Wed Section Meetings: Weekly Thurs Section Meetings: 8:00-9:00 Grand Rounds: ED section meeting (monthly) MRI meeting (Weekly) [TCC-484] 11:00-12:00 MSK clinical conf 12:00 - 1:30 Abd [WCC-354] Quality Assurance [ED annex, WCC] 7:30 - 8:15 call Sheila Blalock 4-2506 12:00-1:00 Thoracic Imaging, 12:00-1:00 MSK Axillary Imaging (Dr. Ferris) GI Oncology/GU Oncology 7:30 - 8:15 Case Conference 12:00 - 1:00 7:30 - 9:00 8:15 - 9:00 3:00-4:00 Mammo [TCC-484] (Dr. Brewer) Neuro conference (Dr. Bhadelia) (Dr. Smith) (Dr. Armada) 7:30 - 9:00 8:15 - 9:00 Case Conference Holiday Call Lottery! (Dr. Rojas) 6 7 8 9 10 7:30 - 9:00 (Dr. Bennett) 7:30 - 8:15 7:30 - 8:15 7:30 - 8:15 12:00 Fleischner Lecture: Fiction Board Review (Women's Fellow) US-TBA (Dr. Romero) Cases for 1st-3rd years (Dr. & facts about breast cancer 10:30-11:30 8:15 - 9:00 Hochman) screening - We should not agree Nuc Med meeting (GZ-103) NM board review (Dr. Donohoe) 8:15 - 9:00 to disagree (Dr. Daniel Kopans, 7:15 - 8:00 US meeting MSK Quarterly QA Conference (Dr. MGH) (WCC-304A Gallery) Eisenberg & Sr Resident) 2:00-3:00 West Med-Rads 13 14 15 16 17 7:30 - 9:00 7:30 - 8:15 7:30 - 8:15 7:30 - 8:15 8:00-9:00 Grand Rounds: (Dr.
  • Date Prepared 4/21/2016 Curriculum Vitae Linda Moy, M.D. New York

    Date Prepared 4/21/2016 Curriculum Vitae Linda Moy, M.D. New York

    Date prepared 4/21/2016 Curriculum Vitae Linda Moy, M.D. New York University Langone Medical Center New York University Cancer Institute Department of Radiology 160 East 34th Street New York, NY 10016 Phone: (212) 731-5353; fax: (212) 731-5554 Email: [email protected] Education Year Degree Field Institution 1986 Diploma Bronx High School of Science 1990 B.A. Biology and Society Cornell University 1994 M.D. Medicine State University of New York, Health Science Center at Brooklyn Postdoctoral Training Year Specialty Director/Mentor Institution 1995 Internal in Medicine Michael Bruno, MD Lenox Hill Hospital 1995 - 1999 Resident, Radiology Steven Amis, MD Albert Einstein/ Montefiore Medical Center 1999 - 2000 Fellowship, Breast Imaging Daniel Kopans, MD Massachusetts General Hospital Licensure and Certification 1994 Diplomate National Board of Medical Examiners 1995 New York State Medical License (#200816), active 1999 Diplomate American Board of Radiology 1999 Massachusetts Medical License, inactive Academic Appointments 1999 - 2000 Clinical Fellow in Radiology Harvard Medical School 2000 - 2001 Instructor of Radiology Harvard Medical School 2002 - 2013 Assistant Professor of Radiology New York University School of Medicine 2014 - present Associate Professor of Radiology New York University School of Medicine Hospital Appointments 2000 - 2001 Attending Radiologist Massachusetts General Hospital 2002 - present Attending Radiologist New York University Langone Medical Center 2002 - present Attending Radiologist Bellevue Hospital 2002 - present Attending Radiologist Gouverneur Health Care Services Other Professional Positions and Visiting Appointments None 1 Awards and Honors 1990 Cum Laude 1990 -1994 State University of New York: Merit-based scholarship for four years 1994 American Medical Women's Association, The Janet M.